NHS: Drugs

(asked on 19th March 2020) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to paragraph 3.21 of the 2019 voluntary scheme for branded medicines pricing and access, when NICE will review the process and methods for the highly specialised technology evaluation programme; and what methodology will be used in that review.


Answered by
Jo Churchill Portrait
Jo Churchill
Minister of State (Department for Work and Pensions)
This question was answered on 27th April 2020

The National Institute for Health and Care Excellence (NICE) has now initiated the review of its technology appraisal and highly specialised technologies methods in line with the commitment made in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access. Further information about the process and timescale for the review is available on the NICE website at the following link:

https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/changes-to-health-technology-evaluation

Reticulating Splines